Emily Field analyst BARCLAYS

Currently out of the existing stock ratings of Emily Field, 24 are a BUY (55.81%), 14 are a HOLD (32.56%), 5 are a SELL (11.63%).

Emily Field

Work Performance Price Targets & Ratings Chart

Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 41.07% that have a potential upside of 5.06% achieved within 70 days.

Emily Field’s has documented 78 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 06-Aug-2024.

Wall Street Analyst Emily Field

Analyst best performing recommendations are on GLPG (GALAPAGOS NV ADR).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 3/2/2021. The price target of $82.77 was fulfilled within 1 day with a profit of $1.59 (1.88%) receiving and performance score of 18.85.

Average potential price target upside

ARGX argenx NV ADR AZN AstraZeneca PLC ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR UCBJY UCB SA ADR SNY Sanofi ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$606

$10.42 (1.75%)

$468

3 days ago
(01-Nov-2024)

13/14 (92.86%)

$10.42 (1.75%)

185

Buy

$665

$69.42 (11.66%)

$585

3 days ago
(01-Nov-2024)

11/12 (91.67%)

$69.42 (11.66%)

163

Buy

$650

$54.42 (9.14%)

$515

3 days ago
(01-Nov-2024)

9/10 (90%)

$54.42 (9.14%)

170

Buy

$617

$21.42 (3.60%)

$533

3 days ago
(01-Nov-2024)

25/26 (96.15%)

$21.42 (3.60%)

170

Buy

$639

$43.42 (7.29%)

$547

3 days ago
(01-Nov-2024)

14/17 (82.35%)

$43.42 (7.29%)

176

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Emily Field is most bullish on?

Potential upside of $0 has been obtained for ARGX (ARGENX NV ADR)

What Year was the first public recommendation made by Emily Field?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?